Stock Research: Faes Farma

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Faes Farma

MCE:FAE ES0134950F36
81
  • Value
    86
  • Growth
    49
  • Safety
    Safety
    79
  • Combined
    98
  • Sentiment
    13
  • 360° View
    360° View
    81
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Faes Farma SA is a Spain-based pharmaceutical company that researches, produces, distributes, and sells drugs, supplements, and personal care treatments, as well as raw materials. Key businesses include prescription and generic drugs, OTC medicines, food supplements, personal care, and animal nutrition products. The company operates in Spain, Portugal, Chile, and Mexico. In the last fiscal year, the company had 1775 employees, a market cap of $1676 million, profits of $338 million, and revenue of $511 million.

more

ANALYSIS: With an Obermatt 360° View of 81 (better than 81% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Faes Farma are very positive. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Faes Farma. The consolidated Value Rank has an attractive rank of 86, which means that the share price of Faes Farma is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 86% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 79. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 13. Professional investors are more confident in 87% other stocks. The consolidated Growth Rank also has a low rank of 49, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 51 of its competitors have better growth. ...read more

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 20-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 86 89 98
Growth
49 35 5 9
Safety
Safety
79 93 94 92
Sentiment
13 85 38 32
360° View
360° View
81 93 70 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
5 5 11 31
Opinions Change
50 72 50 23
Pro Holdings
n/a 100 100 78
Market Pulse
41 84 31 35
Sentiment
13 85 38 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 86 89 98
Growth
49 35 5 9
Safety Safety
79 93 94 92
Combined
98 87 78 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
73 45 63 77
Price vs. Earnings (P/E)
44 72 78 85
Price vs. Book (P/B)
69 61 76 71
Dividend Yield
83 91 86 96
Value
86 86 89 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
82 23 16 10
Profit Growth
49 45 48 41
Capital Growth
25 27 1 16
Stock Returns
42 79 38 46
Growth
49 35 5 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
30 87 80 79
Refinancing
88 52 73 72
Liquidity
66 92 98 96
Safety Safety
79 93 94 92

Similar Stocks

Discover high‑ranked alternatives to Faes Farma and broaden your portfolio horizons.

Strabag

VIE:STR
Country: Austria
Industry: Construction & Engineering
Size: X-Large
Full Stock Analysis

Grifols

MCE:GRF
Country: Spain
Industry: Biotechnology
Size: X-Large
Full Stock Analysis

Ipsen

PAR:IPN
Country: France
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Neoenergia

SAO:NEOE3
Country: Spain
Industry: Electric Utilities
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: